Medigen Vaccine Biologics
Taiwan - TaipeiBiotechnology
Focus: Medigen Vaccine Biologics is a Taiwan-based biotech company founded in 2021 focused on vaccine and biologics development across infectious diseases. The company operates as a pre-revenue stage biotech with a diversified pipeline spanning COVID-19, dengue, influenza, and enterovirus indications.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Medigen Vaccine Biologics
AI assessmentNot HiringNo open roles listed right now. Follow Medigen Vaccine Biologics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
EV71 vaccine
Enterovirus 71 HumanClinical Trials (1)
NCT04072276Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children
N/AHelp build intelligence for Medigen Vaccine Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.